Photo Courtesy: Ayjaz Ahmad Wani
Discover how the U.S. strategy against synthetic opioids combines intelligence-led law enforcement with public health interventions
Syed Sulaiman Akhtar
SPAN magazine
The rise of illegal synthetic drugs is reshaping the global narcotics landscape. Unlike traditional drugs, synthetic opioids such as fentanyl can be produced quickly, transported through complex international supply chains, and distributed through both physical and online networks. Their growing prevalence has pushed governments to rethink how they combat drug trafficking and addiction.
When journalist Pranjit Deka and policy expert Ayjaz Ahmad Wani visited the United States earlier this year as part of an International Visitor Leadership Program (IVLP) on combating drug trafficking, they encountered a response that extends well beyond traditional law enforcement. Across meetings with policymakers, law enforcement officials, researchers, and public health practitioners, they observed how the United States combines intelligence, enforcement, treatment, and international cooperation to address evolving drug threats.
Synthetic drugs as a national security challenge
According to Wani, synthetic opioids have become a major national concern in the United States. The country has experienced a rise in overdose deaths in recent years, driven largely by synthetic opioids, methamphetamine, and cocaine use.
Given the scale of the challenge, the U.S. response increasingly treats drug trafficking and addiction as issues that affect both public health and national security. Wani noted that fentanyl, which causes thousands of deaths annually, is viewed as a threat linked to transnational criminal organizations and global supply chains.
As a result, U.S. agencies employ what Wani describes as a “whole-of-government approach” that combines border security, sanctions, intelligence gathering, asset seizures, diplomatic engagement, and public health measures. The strategy seeks not only to disrupt trafficking networks but also to reduce demand through treatment, prevention, and community outreach.
Intelligence-driven policing in U.S. law enforcement
One of the strongest themes that emerged during the visit was the importance of intelligence-led policing.
Rather than treating synthetic opioids as a localized law enforcement issue, U.S. agencies focus on the criminal networks that produce, transport, finance, and distribute them.
“The U.S. approach here is highly intelligence driven and internationally oriented. Synthetic opioids are not treated as a local issue—they are seen as part of a global criminal network,” says Deka.
During meetings with the Drug Enforcement Administration, the IVLP participants learned how trafficking routes are tracked across multiple countries and how agencies monitor financial flows and online platforms used for drug distribution.
Data sharing across federal and state fusion centers
In Texas, meetings with the Department of Homeland Security and the National Network of Fusion Centers demonstrated how information gathered by border authorities, law enforcement agencies, and financial investigators is brought together and analyzed in real time.
“This kind of real-time, multisource intelligence sharing is critical when dealing with synthetic drugs, which can be produced and trafficked much faster than traditional narcotics,” Deka says.
Wani similarly highlights the role of interagency cooperation. He notes that DEA, FBI, and Homeland Security Investigations fusion centers work together to monitor narcotics networks, while federal, state, and local task forces share information and coordinate investigations.
Shifting focus toward public health and addiction recovery
While law enforcement remains central to the U.S. response, participants were also struck by the emphasis placed on prevention, treatment, and recovery.
“What I found most instructive was the clear shift toward a public health approach,” Deka says. “Addiction is not viewed purely as a criminal issue, but as a chronic health condition that requires treatment and support.”
In Michigan, they observed programs such as the ANGEL initiative, which encourages people struggling with addiction to seek assistance without fear of punishment. Discussions with researchers also highlighted the role of prevention education, community partnerships, and early intervention.
According to Wani, community engagement forms an important part of the broader strategy. He notes that health workers, law enforcement agencies, local authorities, and community organizations work together to reduce demand and expand access to treatment.
“The U.S. treats drug addiction and substance use as a chronic disease, and communities are given access to treatment, such as NARCAN, through community engagement,” he says.
Deka also points to the use of medication-assisted treatment and mental health services as part of efforts to support long-term recovery.
“What really stands out is the effort to reduce stigma, making it easier for people to come forward and seek help,” he says.
How U.S. drug courts connect justice with rehabilitation
The participants also encountered approaches designed to connect the criminal justice system with rehabilitation services.
For Deka, one of the most notable examples was the use of drug courts.
“The concept of drug courts reflects a very practical understanding that not all drug-related offences should lead to incarceration,” he says.
These courts bring together judges, attorneys, probation officers, and treatment providers to guide eligible individuals toward recovery while maintaining accountability.
Wani observed a similar model during a visit to a drug court, where nonviolent offenders were diverted into treatment programs monitored by judges. He notes that local communities and administrative authorities often continue supporting individuals even after recovery by helping them secure employment and reintegrate into their communities.
Coordinating enforcement and policy ecosystems
For both participants, the visit highlighted the extent to which modern drug trafficking transcends borders and requires coordinated responses.
“What struck me most was the depth of coordination and clarity of roles across institutions,” Deka says. “During my visit to Washington, D.C., I saw how policy, enforcement, and public health are not working in isolation but as part of a well-aligned ecosystem.”
Many of the challenges confronting the United States also resonate elsewhere. Wani notes that India faces growing concerns related to synthetic drugs, precursor chemicals, and cross-border trafficking networks. He points to the importance of stronger interagency coordination, information-sharing, and efforts to disrupt trafficking organizations and their financial networks.
For Deka, international cooperation remains essential.
“Drug trafficking today is a global challenge, so collaboration is not optional—it’s essential,” he says.
As synthetic drugs continue to alter the nature of narcotics trafficking, the experiences shared through programs like IVLP offer insights into how governments are adapting their responses. The U.S. approach suggests that addressing modern drug threats requires more than arrests and interdictions. It also demands intelligence sharing, public health interventions, institutional coordination, and international partnerships capable of responding to increasingly complex criminal networks.
